Beijing Comens New MaterialsLtd Past Earnings Performance
Past criteria checks 0/6
Beijing Comens New MaterialsLtd's earnings have been declining at an average annual rate of -30.3%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 2.1% per year.
Key information
-30.3%
Earnings growth rate
-30.2%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 2.1% |
| Return on equity | -21.4% |
| Net Margin | -29.5% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Beijing Comens New MaterialsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,117 | -330 | 116 | 77 |
| 31 Dec 23 | 1,035 | -345 | 115 | 75 |
| 30 Sep 23 | 1,051 | 133 | 118 | 71 |
| 30 Jun 23 | 1,032 | 150 | 115 | 66 |
| 31 Mar 23 | 988 | 138 | 111 | 60 |
| 01 Jan 23 | 1,016 | 141 | 111 | 59 |
| 30 Sep 22 | 996 | 122 | 120 | 64 |
| 30 Jun 22 | 1,018 | 115 | 107 | 66 |
| 31 Mar 22 | 1,077 | 141 | 89 | 66 |
| 31 Dec 21 | 1,100 | 159 | 81 | 64 |
| 30 Sep 21 | 1,129 | 201 | 72 | 63 |
| 30 Jun 21 | 1,102 | 233 | 66 | 62 |
| 31 Mar 21 | 1,070 | 246 | 88 | 59 |
| 31 Dec 20 | 960 | 233 | 87 | 53 |
| 30 Sep 20 | 903 | 224 | 96 | 46 |
| 30 Jun 20 | 899 | 208 | 131 | 47 |
| 31 Mar 20 | 889 | 189 | 117 | 52 |
| 31 Dec 19 | 960 | 186 | 149 | 55 |
| 30 Sep 19 | 981 | 157 | 149 | 52 |
| 30 Jun 19 | 995 | 136 | 140 | 47 |
| 31 Mar 19 | 1,021 | 104 | 155 | 48 |
| 31 Dec 18 | 1,016 | 84 | 128 | 51 |
| 30 Sep 18 | 1,034 | 62 | 140 | 57 |
| 30 Jun 18 | 1,029 | 63 | 109 | 71 |
| 31 Mar 18 | 961 | 60 | 109 | 57 |
| 31 Dec 17 | 854 | 43 | 111 | 43 |
| 30 Sep 17 | 752 | 53 | 104 | 25 |
| 30 Jun 17 | 624 | 37 | 122 | 0 |
| 31 Mar 17 | 557 | 44 | 112 | 0 |
| 31 Dec 16 | 528 | 57 | 110 | 0 |
| 30 Sep 16 | 499 | 63 | 98 | 0 |
| 30 Jun 16 | 487 | 63 | 99 | 0 |
| 31 Mar 16 | 492 | 59 | 102 | 0 |
| 31 Dec 15 | 488 | 54 | 101 | 0 |
| 30 Sep 15 | 492 | 57 | 91 | 0 |
| 30 Jun 15 | 500 | 53 | 90 | 0 |
| 31 Mar 15 | 514 | 51 | 90 | 0 |
| 31 Dec 14 | 518 | 49 | 91 | 0 |
| 30 Sep 14 | 524 | 46 | 94 | 0 |
| 30 Jun 14 | 528 | 51 | 89 | 0 |
| 31 Mar 14 | 505 | 49 | 88 | 0 |
| 31 Dec 13 | 502 | 50 | 83 | 0 |
| 30 Sep 13 | 486 | 49 | 76 | 0 |
| 30 Jun 13 | 455 | 49 | 73 | 0 |
Quality Earnings: 300200 is currently unprofitable.
Growing Profit Margin: 300200 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300200 is unprofitable, and losses have increased over the past 5 years at a rate of 30.3% per year.
Accelerating Growth: Unable to compare 300200's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300200 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.8%).
Return on Equity
High ROE: 300200 has a negative Return on Equity (-21.37%), as it is currently unprofitable.